JP2014502988A5 - - Google Patents

Download PDF

Info

Publication number
JP2014502988A5
JP2014502988A5 JP2013549825A JP2013549825A JP2014502988A5 JP 2014502988 A5 JP2014502988 A5 JP 2014502988A5 JP 2013549825 A JP2013549825 A JP 2013549825A JP 2013549825 A JP2013549825 A JP 2013549825A JP 2014502988 A5 JP2014502988 A5 JP 2014502988A5
Authority
JP
Japan
Prior art keywords
alkyl
ring
group
groups
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013549825A
Other languages
English (en)
Japanese (ja)
Other versions
JP5703393B2 (ja
JP2014502988A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/050841 external-priority patent/WO2012098217A1/en
Publication of JP2014502988A publication Critical patent/JP2014502988A/ja
Publication of JP2014502988A5 publication Critical patent/JP2014502988A5/ja
Application granted granted Critical
Publication of JP5703393B2 publication Critical patent/JP5703393B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013549825A 2011-01-21 2012-01-20 糖尿病、肥満および関連障害の治療のためのgpr119モジュレーターとしての縮合ジヒドロフラン Active JP5703393B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP11151688 2011-01-21
EP11151688.6 2011-01-21
EP11191903 2011-12-05
EP11191903.1 2011-12-05
PCT/EP2012/050841 WO2012098217A1 (en) 2011-01-21 2012-01-20 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders

Publications (3)

Publication Number Publication Date
JP2014502988A JP2014502988A (ja) 2014-02-06
JP2014502988A5 true JP2014502988A5 (enExample) 2014-03-20
JP5703393B2 JP5703393B2 (ja) 2015-04-15

Family

ID=45495952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013549825A Active JP5703393B2 (ja) 2011-01-21 2012-01-20 糖尿病、肥満および関連障害の治療のためのgpr119モジュレーターとしての縮合ジヒドロフラン

Country Status (19)

Country Link
US (1) US8778926B2 (enExample)
EP (1) EP2665719B1 (enExample)
JP (1) JP5703393B2 (enExample)
KR (1) KR20140003496A (enExample)
CN (1) CN103443097A (enExample)
AP (1) AP2013006985A0 (enExample)
AR (1) AR084905A1 (enExample)
AU (1) AU2012208530A1 (enExample)
BR (1) BR112013017669A2 (enExample)
CA (1) CA2825124A1 (enExample)
CO (1) CO6781501A2 (enExample)
EA (1) EA201300846A1 (enExample)
EC (1) ECSP13012800A (enExample)
MA (1) MA34839B1 (enExample)
MX (1) MX2013008083A (enExample)
PH (1) PH12013501515A1 (enExample)
SG (1) SG192036A1 (enExample)
UY (1) UY33871A (enExample)
WO (1) WO2012098217A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010149685A1 (en) 2009-06-24 2010-12-29 Boehringer Ingelheim International Gmbh New compounds, pharmaceutical composition and methods relating thereto
UY33805A (es) 2010-12-17 2012-07-31 Boehringer Ingelheim Int ?Derivados de dihidrobenzofuranil-piperidinilo, aza-dihidrobenzofuranilpiperidinilo y diaza-dihidrobenzofuranil-piperidinilo, composiciones farmacéuticas que los contienen y usos de los mismos?.
EP2686312B1 (en) 2011-03-14 2016-08-31 Boehringer Ingelheim International GmbH N-cyclopropyl-n-piperidinylbenzamides as gpr119 modulators
WO2012168315A1 (en) 2011-06-09 2012-12-13 Boehringer Ingelheim International Gmbh Substituted piperidines as gpr119 modulators for the treatment of metabolic disorders
US8853239B2 (en) * 2011-12-09 2014-10-07 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical compositions and uses thereof
US9012456B2 (en) * 2012-02-28 2015-04-21 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical compositions and uses thereof
EP2847196B1 (en) * 2012-05-07 2017-10-25 Boehringer Ingelheim International GmbH New 2,3-dihydro-furo[2,3-c]pyridines, their use as modulators of the g-protein-coupled receptor gpr119 and pharmaceutical compositions comprising them
EP2872127A1 (en) 2012-07-11 2015-05-20 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
US10208030B2 (en) * 2016-04-08 2019-02-19 Mankind Pharma Ltd. GPR119 agonist compounds
US10526345B2 (en) 2016-04-08 2020-01-07 Mankind Pharma Ltd. Compounds as GPR119 agonists
US10954229B2 (en) 2016-04-08 2021-03-23 Mankind Pharma Ltd. GPR119 agonist compounds
JP7095288B2 (ja) * 2018-01-24 2022-07-05 富士フイルムビジネスイノベーション株式会社 定着装置および画像形成装置
JP7745559B2 (ja) 2020-02-28 2025-09-29 キャリーオペ,インク. Gpr40アゴニスト
BR112022023359A2 (pt) 2020-05-19 2023-04-18 Kallyope Inc Ativadores de ampk
JP2023531726A (ja) 2020-06-26 2023-07-25 キャリーオペ,インク. Ampkアクチベーター
WO2025037213A1 (en) * 2023-08-11 2025-02-20 Mankind Pharma Ltd. Pharmaceutical formulations of gpr119 agonists and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003221386A (ja) * 2001-11-26 2003-08-05 Takeda Chem Ind Ltd 二環性誘導体、その製造法およびその用途
US20090221644A1 (en) * 2005-06-30 2009-09-03 Stuart Edward Bradley Gpcr Agonists
AR064416A1 (es) * 2006-12-21 2009-04-01 Cancer Rec Tech Ltd Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
JPWO2010084944A1 (ja) * 2009-01-22 2012-07-19 田辺三菱製薬株式会社 新規ピロロ[2,3−d]ピリミジン化合物
WO2010149685A1 (en) 2009-06-24 2010-12-29 Boehringer Ingelheim International Gmbh New compounds, pharmaceutical composition and methods relating thereto
AU2010264720A1 (en) 2009-06-24 2011-12-08 Boehringer Ingelheim International Gmbh New compounds, pharmaceutical composition and methods relating thereto
US8431595B2 (en) * 2009-08-20 2013-04-30 The University Of Tennessee Research Foundation Furanopyridine cannabinoid compounds and related methods of use
BR112012028445A2 (pt) * 2010-05-06 2016-07-19 Bristol Myers Squibb Co compostos de heteroarila bicíclica como moduladores de gpr119
US8729084B2 (en) * 2010-05-06 2014-05-20 Bristol-Myers Squibb Company Benzofuranyl analogues as GPR119 modulators
JP5794297B2 (ja) 2010-05-07 2015-10-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Gpr119アゴニストとしてのピリダジノン
UY33805A (es) * 2010-12-17 2012-07-31 Boehringer Ingelheim Int ?Derivados de dihidrobenzofuranil-piperidinilo, aza-dihidrobenzofuranilpiperidinilo y diaza-dihidrobenzofuranil-piperidinilo, composiciones farmacéuticas que los contienen y usos de los mismos?.

Similar Documents

Publication Publication Date Title
JP2014502988A5 (enExample)
JP2014509600A5 (enExample)
JP2014516070A5 (enExample)
JP2014511892A5 (enExample)
JP2013545791A5 (enExample)
JP2014525420A5 (enExample)
JP2016503797A5 (enExample)
HRP20220899T1 (hr) Spojevi policikličkog karbamoilpiridona i njihova farmaceutska uporaba
JP2013507425A5 (enExample)
JP2016506962A5 (enExample)
JP2012513416A5 (enExample)
JP2015504067A5 (enExample)
JP2015516427A5 (enExample)
JP2017537882A5 (enExample)
JP2016506958A5 (enExample)
JP2014514360A5 (enExample)
JP2015500843A5 (enExample)
JP2015511613A5 (enExample)
JP2013542261A5 (enExample)
JP2016506961A5 (enExample)
JP2014511891A5 (enExample)
JP2013509392A5 (enExample)
JP2017503760A5 (enExample)
JP2015500842A5 (enExample)
RU2016137263A (ru) Соединение триазина и его применение в медицинских целях